Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety and Effects of High-Intensity Blood Flow Restriction Training in the Rotator Cuff

NCT: NCT07404683 · NOT_YET_RECRUITING

NCT IDNCT07404683
StatusNOT_YET_RECRUITING
Start Date2026-09
Completion2028-06
SponsorUniversity of Valencia (OTHER)
First posted
Last updated

Brief Summary

This study aims to analyze the effects of an 8-week strength training program combining different exercise intensities and blood flow restriction (BFR) conditions on safety, tolerability, muscle adaptations, and physical performance variables. Three training modalities will be compared: 1) high-intensity exercise with BFR therapy; 2) low-intensity exercise with BFR therapy; and 3) high-intensity exercise without BFR therapy. All groups will perform the same exercise modality, differing only in intensity and the application of BFR. Participants will be randomly assigned to one of the three groups and will undergo a 8-week intervention. The variables of interest will be assessed in each group for subsequent analysis and comparison.

Frequently Asked Questions

What is Safety and Effects of High-Intensity Blood Flow Restriction Training in the Rotator Cuff?

Safety and Effects of High-Intensity Blood Flow Restriction Training in the Rotator Cuff is a clinical trial registered under NCT07404683. Current status: NOT_YET_RECRUITING.

What is the status of NCT07404683?

The current status of NCT07404683 (Safety and Effects of High-Intensity Blood Flow Restriction Training in the Rotator Cuff) is: NOT_YET_RECRUITING.

When did Safety and Effects of High-Intensity Blood Flow Restriction Training in the Rotator Cuff start?

Safety and Effects of High-Intensity Blood Flow Restriction Training in the Rotator Cuff started on 2026-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.